Appendix 2A - Application for quotation of securities Announcement Summary Entity name BLS PHARMACEUTICALS LIMITED Announcement Type New announcement Date of this announcement Monday November 16, 2026 The +securities to be quoted are: +Securities issued, transferred or re-classified as a result of...
Application for quotation of securities - BLS
Filed with ASX · · 7 pages · English
Summary by 6ix AI
BLS Pharmaceuticals Limited has submitted an application for the quotation of securities on the ASX, specifically for new ordinary fully paid shares resulting from the exercise of options and convertible securities. The application details the number of securities to be quoted and confirms that these will rank equally with existing securities in the same class. The total number of quoted securities following this application will be reported, along with the details of unquoted securities still in circulation.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
BLS Pharmaceuticals Limited on 6ix
In the deck
Earlier from BLS Pharmaceuticals
- To Present at Bell Potter Health Care Conference 19.11.2026
- Directors Change of Interest Notice X 2
- Letter to Shareholders re Annual General Meeting
- Notice of Annual General Meeting/Proxy Form
- Q1 FY2027 Quarterly Activities Update
Later from BLS Pharmaceuticals
All BLS Pharmaceuticals news releasesFollow BLS Pharmaceuticals into a list and get an email when it puts out news.
Follow BLS Pharmaceuticals